Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.13Price to Sales
VS
Market
Sector
Industry
History
$ 2.01Close
$ 1.08 - $ 4.59 52-Week Range
Ticker Information
Ticker
ACRSCompany Name
ACLARIS THERAPEUTICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQACLARIS THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ACRS - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 170.08M | 10.13 | $ 16.79M |
| 3/31/2025 | $ 141.85M | 7.98 | $ 17.78M |
| 12/31/2024 | $ 210.44M | 11.24 | $ 18.72M |
| 9/30/2024 | $ 161.43M | 5.96 | $ 27.08M |
| 6/30/2024 | $ 84.9M | 2.65 | $ 32.02M |
| 3/31/2024 | $ 95.49M | 3.07 | $ 31.12M |
| 12/31/2023 | $ 85.11M | 2.72 | $ 31.25M |
| 9/30/2023 | $ 388.18M | 18.11 | $ 21.43M |
| 6/30/2023 | $ 647.06M | 20.76 | $ 31.17M |
| 3/31/2023 | $ 593.71M | 19.26 | $ 30.83M |
Key Performance Insights, Last 5 Years
- ACLARIS THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 28.27.
- Over the past 5 years, ACLARIS THERAPEUTICS INC's average P/S has been 61.6.
- The median P/S for ACLARIS THERAPEUTICS INC during this period was 24.51
- ACLARIS THERAPEUTICS INC reached its highest P/S over the past 5 years at 174.53.
- The lowest P/S recorded by ACLARIS THERAPEUTICS INC in the same timeframe 2.65
ACLARIS THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ACLARIS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 169.53M ] / Revenues [ $ 6M ]
(=) P/S [ 28.27 ] ACRS - Price to Sales, Last 5 years
2.65
Minimum
Jun 30, 2024
174.53
Maximum
Mar 31, 2021
61.6
Average
24.51
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |